|
1
|
Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial.
|
JAMA
|
2002
|
4.94
|
|
2
|
The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease.
|
Mayo Clin Proc
|
2012
|
3.45
|
|
3
|
Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma.
|
Br J Haematol
|
2004
|
2.91
|
|
4
|
Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial.
|
J Am Coll Cardiol
|
2005
|
2.62
|
|
5
|
Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma.
|
Clin Oncol (R Coll Radiol)
|
2004
|
2.35
|
|
6
|
Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in patients with high-risk acute myeloid leukemia and myelodysplasia.
|
J Clin Oncol
|
2005
|
2.20
|
|
7
|
Burkitt's lymphoma.
|
Lancet
|
2012
|
2.02
|
|
8
|
Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference).
|
Am J Cardiol
|
2005
|
1.83
|
|
9
|
Time course of the interaction between tadalafil and nitrates.
|
J Am Coll Cardiol
|
2003
|
1.71
|
|
10
|
Contribution of problem drug users' deaths to excess mortality in Scotland: secondary analysis of cohort study.
|
BMJ
|
2008
|
1.69
|
|
11
|
Prognostic utility of erectile dysfunction for cardiovascular disease in younger men and those with diabetes.
|
Am Heart J
|
2012
|
1.65
|
|
12
|
Low testosterone associated with obesity and the metabolic syndrome contributes to sexual dysfunction and cardiovascular disease risk in men with type 2 diabetes.
|
Diabetes Care
|
2011
|
1.60
|
|
13
|
Evidence based medicine inevitably increases testosterone prescribing.
|
BMJ
|
2012
|
1.54
|
|
14
|
Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation.
|
Blood
|
2011
|
1.50
|
|
15
|
Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping.
|
Blood
|
2008
|
1.45
|
|
16
|
Diagnosis and management of acute graft-versus-host disease.
|
Br J Haematol
|
2012
|
1.43
|
|
17
|
Summary of the recommendations on sexual dysfunctions in men.
|
J Sex Med
|
2010
|
1.42
|
|
18
|
Less than half of patients aged 65 years or under with myeloma proceed to transplantation: results of a two region population-based survey.
|
Br J Haematol
|
2005
|
1.41
|
|
19
|
Believe-it then PROVE-IT.
|
Int J Clin Pract
|
2004
|
1.39
|
|
20
|
Giving up smoking.
|
Hosp Med
|
2004
|
1.39
|
|
21
|
CEMO in a UK stallion.
|
Vet Rec
|
2002
|
1.39
|
|
22
|
Regional heterogeneity of cellular prion protein isoforms in the mouse brain.
|
Brain
|
2003
|
1.37
|
|
23
|
Prognostic significance of NOD2/CARD15 variants in HLA-identical sibling hematopoietic stem cell transplantation: effect on long-term outcome is confirmed in 2 independent cohorts and may be modulated by the type of gastrointestinal decontamination.
|
Blood
|
2006
|
1.32
|
|
24
|
Evidence evaluation: a response to the court of appeal judgment in R v T.
|
Sci Justice
|
2011
|
1.30
|
|
25
|
Interpreting small quantities of DNA: the hierarchy of propositions and the use of Bayesian networks.
|
J Forensic Sci
|
2002
|
1.20
|
|
26
|
Suicide trends and geographical variations in the United Kingdom, 1991-2004.
|
Health Stat Q
|
2006
|
1.19
|
|
27
|
Interaction between the phosphodiesterase 5 inhibitor, tadalafil and 2 alpha-blockers, doxazosin and tamsulosin in healthy normotensive men.
|
J Urol
|
2004
|
1.16
|
|
28
|
Trends and geographical variations in alcohol-related deaths in the United Kingdom, 1991-2004.
|
Health Stat Q
|
2007
|
1.12
|
|
29
|
Therapeutic action of citrate in urolithiasis explained by chemical speciation: increase in pH is the determinant factor.
|
Nephrol Dial Transplant
|
2005
|
1.11
|
|
30
|
Relation of erectile dysfunction to angiographic coronary artery disease.
|
Am J Cardiol
|
2003
|
1.10
|
|
31
|
Allogeneic stem cell transplantation for myelofibrosis in 2012.
|
Br J Haematol
|
2012
|
1.08
|
|
32
|
Management of cytomegalovirus infection in haemopoietic stem cell transplantation.
|
Br J Haematol
|
2013
|
1.06
|
|
33
|
Efficacy of monotherapy compared with combined antianginal drugs in the treatment of chronic stable angina pectoris: a meta-analysis.
|
Coron Artery Dis
|
2002
|
1.03
|
|
34
|
Diagnosis and treatment of erectile dysfunction for reduction of cardiovascular risk.
|
J Urol
|
2013
|
0.97
|
|
35
|
Attention-deficit hyperactivity disorder across the lifespan.
|
Br J Psychiatry
|
2013
|
0.97
|
|
36
|
Erectile dysfunction in the cardiovascular patient.
|
Eur Heart J
|
2013
|
0.96
|
|
37
|
Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference).
|
Am J Cardiol
|
2005
|
0.91
|
|
38
|
Changes in the human mitochondrial genome after treatment of malignant disease.
|
Mutat Res
|
2003
|
0.90
|
|
39
|
Organ-specific management and supportive care in chronic graft-versus-host disease.
|
Br J Haematol
|
2012
|
0.90
|
|
40
|
Counting the dead and what they died of.
|
Bull World Health Organ
|
2006
|
0.90
|
|
41
|
Diagnosis and management of chronic graft-versus-host disease.
|
Br J Haematol
|
2012
|
0.90
|
|
42
|
A randomised controlled trial of cognitive behaviour therapy vs treatment as usual in the treatment of mild to moderate late life depression.
|
Int J Geriatr Psychiatry
|
2008
|
0.89
|
|
43
|
A functional variant in the core promoter of the CD95 cell death receptor gene predicts prognosis in acute promyelocytic leukemia.
|
Blood
|
2011
|
0.89
|
|
44
|
Aspirin acetylates nitric oxide synthase type 3 in platelets thereby increasing its activity.
|
Cardiovasc Res
|
2009
|
0.87
|
|
45
|
Coronary and systemic hemodynamic effects of sildenafil citrate: from basic science to clinical studies in patients with cardiovascular disease.
|
Int J Cardiol
|
2002
|
0.86
|
|
46
|
Thalidomide maintenance following high-dose therapy in multiple myeloma: a UK myeloma forum phase 2 study.
|
Br J Haematol
|
2007
|
0.86
|
|
47
|
Erectile dysfunction and cardiac disease: recommendations of the Second Princeton Conference.
|
Curr Urol Rep
|
2006
|
0.86
|
|
48
|
Cardiovascular safety update of Tadalafil: retrospective analysis of data from placebo-controlled and open-label clinical trials of Tadalafil with as needed, three times-per-week or once-a-day dosing.
|
Am J Cardiol
|
2006
|
0.85
|
|
49
|
Aspirin modifies nitric oxide synthase activity in platelets: effects of acute versus chronic aspirin treatment.
|
Cardiovasc Res
|
2003
|
0.85
|
|
50
|
Erectile dysfunction: a marker of silent coronary artery disease.
|
Eur Heart J
|
2006
|
0.85
|
|
51
|
Simulating calcium salt precipitation in the nephron using chemical speciation.
|
Urol Res
|
2011
|
0.85
|
|
52
|
Regulatory T-cell suppression of CD8+ T-cell-mediated graft-versus-host reaction requires their presence during priming.
|
Transplantation
|
2009
|
0.84
|
|
53
|
Prognostic significance of interleukin-7 receptor-α gene polymorphisms in allogeneic stem-cell transplantation: a confirmatory study.
|
Transplantation
|
2011
|
0.83
|
|
54
|
Pharmacotherapy for erectile dysfunction.
|
J Sex Med
|
2004
|
0.83
|
|
55
|
A polymorphism in the 3' UTR of IRF4 linked to susceptibility and pathogenesis in chronic lymphocytic leukaemia and Hodgkin lymphoma has limited impact in multiple myeloma.
|
Br J Haematol
|
2010
|
0.82
|
|
56
|
Phosphodiesterase type 5 inhibitors improve endothelial function and may benefit cardiovascular conditions.
|
Am J Med
|
2013
|
0.82
|
|
57
|
The metabolic syndrome and erectile dysfunction: multiple vascular risk factors and hypogonadism.
|
Eur Urol
|
2006
|
0.81
|
|
58
|
Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study.
|
BJU Int
|
2007
|
0.81
|
|
59
|
Cardiovascular risk factors determine erectile and arterial function response to sildenafil.
|
Am J Hypertens
|
2006
|
0.81
|
|
60
|
Asymmetric dimethyl arginine levels correlate with cardiovascular risk factors in patients with erectile dysfunction.
|
Atherosclerosis
|
2005
|
0.80
|
|
61
|
Epstein-Barr virus-independent diffuse large B-cell lymphoma in DNA ligase 4 deficiency.
|
J Allergy Clin Immunol
|
2012
|
0.80
|
|
62
|
Erectile dysfunction in general medicine.
|
Clin Med
|
2013
|
0.79
|
|
63
|
A male cardiovascular sexual health clinic.
|
Int J Clin Pract
|
2002
|
0.79
|
|
64
|
Vardenafil--PDE5 inhibitor number 3.
|
Int J Clin Pract
|
2004
|
0.79
|
|
65
|
Comparative pre-clinical evaluation of receptor tyrosine kinase inhibitors for the treatment of multiple myeloma.
|
Leuk Res
|
2011
|
0.79
|
|
66
|
Whole body nitric oxide production is not decreased in patients with coronary atherosclerosis but is inversely related to plasma homocysteine.
|
Atherosclerosis
|
2007
|
0.78
|
|
67
|
NO problem: arterial and venous endothelial function and erectile dysfunction.
|
Eur Urol
|
2011
|
0.78
|
|
68
|
PDE 5 inhibitors and HIV risk: current concepts and controversies.
|
Int J Clin Pract
|
2005
|
0.78
|
|
69
|
Cost-effectiveness of preoperative positron emission tomography in ischemic heart disease.
|
Ann Thorac Surg
|
2002
|
0.78
|
|
70
|
Testosterone deficiency syndrome (TDS) and the heart.
|
Eur Heart J
|
2010
|
0.77
|
|
71
|
Aspirin and clopidogrel treatment impair nitric oxide biosynthesis by platelets.
|
J Mol Cell Cardiol
|
2008
|
0.77
|
|
72
|
Obstructive sleep apnoea - a marker of increased cardiovascular risk.
|
Int J Clin Pract
|
2012
|
0.77
|
|
73
|
Female sexual dysfunction: the BMJ fails to educate and fails to debate.
|
Int J Clin Pract
|
2003
|
0.76
|
|
74
|
Skin explant model of human graft-versus-host disease: prediction of clinical outcome and correlation with biological risk factors.
|
Biol Blood Marrow Transplant
|
2006
|
0.76
|
|
75
|
Erectile dysfunction and hypertension.
|
Int J Clin Pract
|
2002
|
0.76
|
|
76
|
"Oh ... by the way ... ": doorknob syndrome.
|
Int J Clin Pract
|
2005
|
0.76
|
|
77
|
Survey for Taylorella species in the UK.
|
Vet Rec
|
2006
|
0.75
|
|
78
|
Stitched up by fake drugs: counterfeits need counteraction.
|
Int J Clin Pract
|
2010
|
0.75
|
|
79
|
Erectile dysfunction in congenital heart disease.
|
Heart
|
2009
|
0.75
|
|
80
|
A comparative study of reduced dose alemtuzumab in matched unrelated donor and related donor reduced intensity transplants.
|
Br J Haematol
|
2015
|
0.75
|
|
81
|
Editorial comment on: Amino-terminal pro-C-type natriuretic peptide is associated with the presence, severity, and duration of vasculogenic erectile dysfunction.
|
Eur Urol
|
2008
|
0.75
|
|
82
|
The politics of life, sex and the family--rediscovering priorities for 2007.
|
Int J Clin Pract
|
2007
|
0.75
|
|
83
|
Phosphodiesterase inhibition: erectile dysfunction is only part of the story.
|
Int J Clin Pract
|
2002
|
0.75
|
|
84
|
Let's talk about sex.
|
Clin Res Cardiol
|
2013
|
0.75
|
|
85
|
Brain cancer in interventional cardiologists and physicians - is occupational radiation exposure the cause?
|
Int J Clin Pract
|
2012
|
0.75
|
|
86
|
Testosterone - not just a replacement therapy.
|
Int J Clin Pract
|
2006
|
0.75
|
|
87
|
Potentially novel segmental polioencephalomyelitis in weaner pigs.
|
Vet Rec
|
2004
|
0.75
|
|
88
|
Erectile dysfunction and vascular risk: Let's get it right.
|
Eur Urol
|
2006
|
0.75
|
|
89
|
Safety and compliance of intravenous and oral dosing regimens.
|
Oncologist
|
2005
|
0.75
|
|
90
|
Evil: origins and potential solutions.
|
Int J Clin Pract
|
2002
|
0.75
|
|
91
|
Letter regarding article by Gazzaruso et al, "Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated, type 2 diabetic patients".
|
Circulation
|
2005
|
0.75
|
|
92
|
The importance of inhibiting free fatty acid metabolism in heart failure treatment.
|
Int J Clin Pract
|
2007
|
0.75
|
|
93
|
The value of VALUE: the importance of lowering blood pressure quickly.
|
Int J Clin Pract
|
2004
|
0.75
|
|
94
|
Are you sure--the importance of "reasonable doubts".
|
Int J Clin Pract
|
2004
|
0.75
|
|
95
|
Mind the (gender) gap.
|
Int J Clin Pract
|
2011
|
0.75
|
|
96
|
Hypertension: treating the patient as well as the blood pressure.
|
Int J Clin Pract
|
2003
|
0.75
|
|
97
|
Remembering Paul.
|
Int J Clin Pract
|
2002
|
0.75
|
|
98
|
Calcium antagonists: a scandal in need of an inquiry.
|
Int J Clin Pract
|
2003
|
0.75
|
|
99
|
Primary angioplasty in acute myocardial infarction - the preferred option, but time is of the essence.
|
Int J Clin Pract
|
2006
|
0.75
|
|
100
|
Losing good friends and good people.
|
Int J Clin Pract
|
2012
|
0.75
|
|
101
|
Reflections.
|
Int J Clin Pract
|
2005
|
0.75
|
|
102
|
"Nuts, whole hazelnuts, Cadbury's take 'em and cover them with chocolate".
|
Int J Clin Pract
|
2010
|
0.75
|
|
103
|
The neglected elderly.
|
Int J Clin Pract
|
2010
|
0.75
|
|
104
|
Case reports.
|
Int J Clin Pract Suppl
|
2005
|
0.75
|
|
105
|
Generic prescribing--cost saving chaos.
|
Int J Clin Pract
|
2005
|
0.75
|
|
106
|
PDE5 inhibitors: looking beyond ED.
|
Int J Clin Pract
|
2003
|
0.75
|
|
107
|
Between the bombs.
|
Int J Clin Pract
|
2003
|
0.75
|
|
108
|
Statins--threatening the evidence base of effectiveness and safety.
|
Int J Clin Pract
|
2004
|
0.75
|
|
109
|
ASTEROID--when spinning a star leads to a collision with reality.
|
Int J Clin Pract
|
2006
|
0.75
|
|
110
|
Transition.
|
Int J Clin Pract
|
2013
|
0.75
|
|
111
|
Expert abuse syndrome: the scapegoating of Roy Meadow.
|
Int J Clin Pract
|
2005
|
0.75
|
|
112
|
Vascular risk factors and erectile dysfunction: 'sexing-up' the importance of lifestyle changes.
|
Int J Clin Pract
|
2007
|
0.75
|
|
113
|
Erectile dysfunction: the need to be evaluated, the right to be treated.
|
Am Heart J
|
2005
|
0.75
|
|
114
|
Caution: critical illness policies.
|
Int J Clin Pract
|
2011
|
0.75
|
|
115
|
Pressure of work and overtime shortens life.
|
Int J Clin Pract
|
2011
|
0.75
|
|
116
|
Sexual medicine is preventative medicine.
|
Int J Clin Pract
|
2012
|
0.75
|
|
117
|
Stable and also unstable coronary disease--COURAGE and the importance of optimal medical therapy.
|
Int J Clin Pract
|
2007
|
0.75
|
|
118
|
Endothelial function and dysfunction.
|
Int J Clin Pract
|
2004
|
0.75
|
|
119
|
Late onset hypogonadism in males - think of it - act on it.
|
Int J Clin Pract
|
2012
|
0.75
|
|
120
|
Finding time for family life and personal health.
|
Int J Clin Pract
|
2005
|
0.75
|
|
121
|
Reclaiming the National Health Service from political control.
|
Int J Clin Pract
|
2007
|
0.75
|
|
122
|
Painful reflections.
|
Int J Clin Pract
|
2007
|
0.75
|
|
123
|
Prevention of disease--education makes a difference in the community.
|
Int J Clin Pract
|
2005
|
0.75
|
|
124
|
Diabetic and hypertension guidelines updated.
|
Int J Clin Pract
|
2004
|
0.75
|
|
125
|
Beta-blockers for uncomplicated hypertension -- mugged by armchair scientists?
|
Int J Clin Pract
|
2006
|
0.75
|
|
126
|
Case reports.
|
Int J Clin Pract
|
2005
|
0.75
|
|
127
|
Generic prescribing -- the chaos continues.
|
Int J Clin Pract
|
2005
|
0.75
|
|
128
|
Standard operative procedures in sexual medicine: a cardiological vacuum.
|
Int J Clin Pract
|
2013
|
0.75
|
|
129
|
A prank too far.
|
Int J Clin Pract
|
2013
|
0.75
|
|
130
|
She should have been at home having tea and cakes.
|
Int J Clin Pract
|
2002
|
0.75
|
|
131
|
Erectile dysfunction, like diabetes, should be considered a 'cardiovascular equivalent'.
|
Int J Clin Pract
|
2005
|
0.75
|
|
132
|
The British Society for Haematology: 'What have the Romans ever done for us?'.
|
Br J Haematol
|
2015
|
0.75
|
|
133
|
Spending less--achieving more.
|
Int J Clin Pract
|
2004
|
0.75
|
|
134
|
Smoking: suicide for some, manslaughter for others--time for a ban in all public places.
|
Int J Clin Pract
|
2004
|
0.75
|
|
135
|
The twists of fate--the role of chance--the joy of life.
|
Int J Clin Pract
|
2002
|
0.75
|
|
136
|
Touching a chord--on being a doctor.
|
Int J Clin Pract
|
2002
|
0.75
|
|
137
|
The cardiac urologist.
|
Int J Clin Pract
|
2007
|
0.75
|
|
138
|
Sexual medicine society of North America.
|
Int J Clin Pract
|
2006
|
0.75
|
|
139
|
Men's health in Europe - no room for complacency.
|
Int J Clin Pract
|
2012
|
0.75
|
|
140
|
Should erectile dysfunction be treated as secondary prevention for coronary disease?
|
Int J Clin Pract
|
2006
|
0.75
|
|
141
|
Blood pressure lowering--is degree more important than method?
|
Int J Clin Pract
|
2005
|
0.75
|
|
142
|
Suicide: using a tragedy to prevent tragedy.
|
Int J Clin Pract
|
2003
|
0.75
|
|
143
|
And so this is Christmas--.
|
Int J Clin Pract
|
2012
|
0.75
|
|
144
|
Smoking politics.
|
Int J Clin Pract
|
2004
|
0.75
|
|
145
|
Lipids and cardiovascular risk reduction -- new targets, new challenges.
|
Int J Clin Pract
|
2005
|
0.75
|
|
146
|
Science & justice.
|
Sci Justice
|
2006
|
0.75
|
|
147
|
Denial.
|
Int J Clin Pract
|
2006
|
0.75
|
|
148
|
The Polypill - multiple drug combinations are not the answer.
|
Int J Clin Pract
|
2011
|
0.75
|
|
149
|
Stable angina--medical therapy gives us time to optimise management.
|
Int J Clin Pract
|
2004
|
0.75
|
|
150
|
Women and heart disease: a British Heart Foundation initiative.
|
Int J Clin Pract
|
2003
|
0.75
|
|
151
|
Evidence-based freedom: first do no harm.
|
Int J Clin Pract
|
2012
|
0.75
|
|
152
|
A two-tier NHS in a two-tier world--time for change.
|
Int J Clin Pract
|
2003
|
0.75
|
|
153
|
Cost-effectiveness of pentostatin compared with cladribine in the management of hairy cell leukemia in the United Kingdom.
|
Clin Ther
|
2009
|
0.75
|
|
154
|
Erectile dysfunction: a management algorithm.
|
Int J Clin Pract
|
2004
|
0.75
|
|
155
|
Conflict of interest: Full disclosure is essential.
|
Int J Clin Pract
|
2006
|
0.75
|
|
156
|
Erectile dysfunction: a window of opportunity for preventing vascular disease?
|
Int J Clin Pract
|
2003
|
0.75
|
|
157
|
Shine a little light--a concert for peace.
|
Int J Clin Pract
|
2007
|
0.75
|
|
158
|
Blood pressure and cardiovascular risk reduction--new targets, new challenges.
|
Int J Clin Pract
|
2005
|
0.75
|
|
159
|
Metabolic approach to heart failure - evidence that trimetazidine improves symptoms, left ventricular function and possibly prognosis.
|
Int J Clin Pract
|
2006
|
0.75
|
|
160
|
Ranolazine--a nicely timed new medical therapy for stable angina.
|
Int J Clin Pract
|
2007
|
0.75
|
|
161
|
Prejudice and perspective.
|
Int J Clin Pract
|
2003
|
0.75
|
|
162
|
The second Princeton consensus on sexual dysfunction and cardiac risk: new guidelines, new challenges.
|
Int J Clin Pract
|
2006
|
0.75
|
|
163
|
Sildenafil (Viagra): new data, new confidence in treating erectile dysfunction in the cardiovascular patient.
|
Int J Clin Pract
|
2002
|
0.75
|
|
164
|
At times like these..
|
Int J Clin Pract
|
2002
|
0.75
|